Aruwon Limited
Strategic consultancy for life science companies and investors
Company Case Studies
Synthetic DNA
Manufacturer
Client was a privately financed synthetic DNA company seeking Series A finance. Aruwon prepared the investment memorandum, investor materials and website content; identified and approached potential investors. Valued at >$1bn at its last financing, the company is the UK's first synthetic biology Unicorn.
Ophthalmology
Drug Developer
Client was a private ophthalmology start-up which had developed a proprietary ophthalmic analgesic and was seeking finance and co-development partners. Aruwon provided interim management, secured 'bridging' finance through an Asian option payment and subsequently a major European development partner.
Life Science
Asian Multinational
Client was an Asian-listed multinational with a $9 billion turnover, active in chemicals and life sciences. The client was seeking life science investment and acquisition opportunities. Aruwon provided an analysis of the opportunity landscape, identified and approached potential targets.
Molecular Diagnostics
Supplier
Client was a private, profitable molecular diagnostics company aiming to enter new markets and gain access to new technology. Initially approached to advise on an acquisition approach, Aruwon was retained as a corporate advisor, identified and secured distribution partners in new major territories. The client has subsequently been acquired by one of the world's leading medical imaging and diagnostics companies.
Bioseparation
Technology Supplier
Client was a private, revenue-generating life science technology company with a proprietary bioseparation technology, which was seeking finance for business expansion. Aruwon was approached to help with financing and recommended seeking a corporate strategic investor. Aruwon successfully identified and secured a multinational partner, leading to an equity investment and a co-development and co-marketing agreement.